CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00637247
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:21.673892+00:00
Published At: 2010-11-30T00:00:00+00:00
Record Updated At: 2019-03-20
Results Posted At: 2010-11-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pancreatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-03-20"
protocolSection.identificationModule.nctId: "NCT00637247"
protocolSection.identificationModule.officialTitle: "A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon\u00ae Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Na\u00efve Pancreatic Adenocarcinoma (Stage IV)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-11-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.